Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Diluvio

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Future Science OA|November 25, 2020
Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticariaLaura Diluvio, Arianna Piccolo, Francesco Marasco, et al.
Drug Design, Development and Therapy|November 26, 2015
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursorsElena Campione, Evelin Jasmine Paternò, Eleonora Candi, et al.
Expert Opinion on Investigational Drugs|June 25, 2019
Investigational drugs currently in phase II clinical trials for actinic keratosisFlavia Lozzi, Caterina Lanna, Mauro Mazzeo, et al.
BMC Research Notes|December 19, 2014
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reportsElena Campione, Laura Diluvio, Alessandro Terrinoni, et al.
Clinics and Practice|February 26, 2026
Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib TherapyEnrico Matteini, Fabio Artosi, Giacomo Caldarola, et al.
Immunotherapy|September 22, 2020
Omalizumab and adalimumab: a winning coupleLaura Diluvio, Laura Vollono, Arianna Zangrilli, et al.
Drug Design, Development and Therapy|March 4, 2015
Tazarotene as alternative topical treatment for onychomycosisElena Campione, Evelin Jasmine Paternò, Gaetana Costanza, et al.
Clinical, Cosmetic and Investigational Dermatology|October 10, 2024
Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case SeriesEnrico Matteini, Laura Diluvio, Sara Lambiase, et al.
Journal of Cosmetic Dermatology|July 15, 2021
Effectiveness of a cosmetic device containing a combination of alpha- and beta-hydroxy acids, urea, and thuja for the treatment of seborrheic keratosesElena Campione, Terenzio Cosio, Monia Di Prete, et al.
BMC Dermatology|April 18, 2014
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomasLaura Diluvio, Claudia Torti, Alessandro Terrinoni, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Future Science OA|November 25, 2020
Improving of psychological status and inflammatory biomarkers during omalizumab for chronic spontaneous urticariaLaura Diluvio, Arianna Piccolo, Francesco Marasco, et al.
Drug Design, Development and Therapy|November 26, 2015
The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursorsElena Campione, Evelin Jasmine Paternò, Eleonora Candi, et al.
Expert Opinion on Investigational Drugs|June 25, 2019
Investigational drugs currently in phase II clinical trials for actinic keratosisFlavia Lozzi, Caterina Lanna, Mauro Mazzeo, et al.
BMC Research Notes|December 19, 2014
Severe erytrodermic psoriasis in child twins: from clinical-pathological diagnosis to treatment of choice through genetic analyses: two case reportsElena Campione, Laura Diluvio, Alessandro Terrinoni, et al.
Clinics and Practice|February 26, 2026
Psoriasis Course in Patients with Alopecia Areata Undergoing Baricitinib TherapyEnrico Matteini, Fabio Artosi, Giacomo Caldarola, et al.
Immunotherapy|September 22, 2020
Omalizumab and adalimumab: a winning coupleLaura Diluvio, Laura Vollono, Arianna Zangrilli, et al.
Drug Design, Development and Therapy|March 4, 2015
Tazarotene as alternative topical treatment for onychomycosisElena Campione, Evelin Jasmine Paternò, Gaetana Costanza, et al.
Clinical, Cosmetic and Investigational Dermatology|October 10, 2024
Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case SeriesEnrico Matteini, Laura Diluvio, Sara Lambiase, et al.
Journal of Cosmetic Dermatology|July 15, 2021
Effectiveness of a cosmetic device containing a combination of alpha- and beta-hydroxy acids, urea, and thuja for the treatment of seborrheic keratosesElena Campione, Terenzio Cosio, Monia Di Prete, et al.
BMC Dermatology|April 18, 2014
Dermoscopy as an adjuvant tool for detecting skin leiomyomas in patient with uterine fibroids and cerebral cavernomasLaura Diluvio, Claudia Torti, Alessandro Terrinoni, et al.
Pageof 7